SG11201508448RA - Heterocyclic acetamide compound - Google Patents
Heterocyclic acetamide compoundInfo
- Publication number
- SG11201508448RA SG11201508448RA SG11201508448RA SG11201508448RA SG11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA SG 11201508448R A SG11201508448R A SG 11201508448RA
- Authority
- SG
- Singapore
- Prior art keywords
- acetamide compound
- heterocyclic
- heterocyclic acetamide
- compound
- acetamide
- Prior art date
Links
- -1 Heterocyclic acetamide compound Chemical class 0.000 title 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013087151 | 2013-04-18 | ||
| PCT/JP2014/061007 WO2014171528A1 (en) | 2013-04-18 | 2014-04-18 | Heterocyclic acetic acid amide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201508448RA true SG11201508448RA (en) | 2015-11-27 |
Family
ID=51729480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201508448RA SG11201508448RA (en) | 2013-04-18 | 2014-04-18 | Heterocyclic acetamide compound |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US8937087B2 (en) |
| EP (1) | EP2987793B1 (en) |
| JP (1) | JP6252582B2 (en) |
| KR (1) | KR102193247B1 (en) |
| CN (1) | CN105121435B (en) |
| AR (1) | AR095883A1 (en) |
| AU (1) | AU2014254768B2 (en) |
| BR (1) | BR112015026512B1 (en) |
| CA (1) | CA2909783C (en) |
| CY (1) | CY1119754T1 (en) |
| DK (1) | DK2987793T3 (en) |
| EA (1) | EA028968B1 (en) |
| ES (1) | ES2651866T3 (en) |
| HR (1) | HRP20171786T1 (en) |
| HU (1) | HUE036054T2 (en) |
| IL (1) | IL241962B (en) |
| LT (1) | LT2987793T (en) |
| ME (1) | ME02891B (en) |
| MX (1) | MX2015014646A (en) |
| MY (1) | MY175971A (en) |
| NO (1) | NO2987793T3 (en) |
| NZ (1) | NZ713118A (en) |
| PH (1) | PH12015502341B1 (en) |
| PL (1) | PL2987793T3 (en) |
| PT (1) | PT2987793T (en) |
| RS (1) | RS56865B1 (en) |
| SA (1) | SA515370015B1 (en) |
| SG (1) | SG11201508448RA (en) |
| SI (1) | SI2987793T1 (en) |
| SM (1) | SMT201700594T1 (en) |
| TW (1) | TWI625329B (en) |
| UA (1) | UA116243C2 (en) |
| WO (1) | WO2014171528A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105025A1 (en) * | 2015-06-19 | 2017-08-30 | Astellas Pharma Inc | IMIDAZODIAZEPIN COMPOUND |
| TWI725408B (en) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | Dopamine d1 receptor positive allosteric modulators |
| WO2020053282A1 (en) | 2018-09-13 | 2020-03-19 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
| CN110590576A (en) * | 2019-08-15 | 2019-12-20 | 安徽金禾实业股份有限公司 | Preparation method of 4-polyfluoro methoxy o-phenylenediamine |
| CN114380709B (en) * | 2021-12-31 | 2023-07-21 | 西北农林科技大学 | The synthetic method of 4-chloro-2-acylaminophenol |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2674524B1 (en) * | 1991-03-25 | 1993-05-21 | Adir | NOVEL HETEROCYCLIC ALKYL AMIDES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| BR0009539A (en) | 1999-04-02 | 2006-06-06 | Neurogen Corp | compound, pharmaceutical composition, method for treating or preventing a disease or disorder associated with pathogenic agonism, inverse agonism or antagonism of the gaba receptor, use of a compound, method for locating gaba receptors in a tissue sample, method for altering gaba a receptor signal transducer activity, method for treating or preventing psychological disorders associated with modulation of the gaba a receptor complex, and process for preparing a compound |
| US6627624B1 (en) | 1999-04-02 | 2003-09-30 | Neurogen Corporation | Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| AUPQ309399A0 (en) | 1999-09-28 | 1999-10-21 | Fujisawa Pharmaceutical Co., Ltd. | Benzothiazoline derivatives |
| ES2349118T3 (en) | 2001-09-14 | 2010-12-28 | High Point Pharmaceuticals, Llc | NEW DERIVATIVES OF AMINOAZETIDINE, PIRROLIDINE AND PIPERIDINE. |
| US7361671B2 (en) | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
| WO2003077847A2 (en) | 2002-03-12 | 2003-09-25 | Merck & Co., Inc. | Substituted amides |
| WO2004082605A2 (en) | 2003-03-14 | 2004-09-30 | Merck & Co. Inc. | Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| CA2554774A1 (en) * | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | Novel heterocyclic compound |
| DE602005016244D1 (en) | 2004-05-27 | 2009-10-08 | Ucb Pharma Sa | BENZOXAZOLE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR APPLICATIONS |
| US7790726B2 (en) | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
| WO2007044885A2 (en) | 2005-10-11 | 2007-04-19 | Chemocentryx, Inc. | Piperidine derivatives and methods of use |
| CL2007002097A1 (en) | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compounds derived from pyrrolidine or morpholine antagonists of urotensin ii; pharmaceutical composition comprising said compounds; and its use to treat congestive heart failure, ischemic heart failure, angina, myocardial ischemia, overactive bladder, asthma and / or copd, among others. |
| US7786157B2 (en) | 2007-03-16 | 2010-08-31 | Chemocentryx, Inc. | OXO-imidazolidines as modulators of chemokine receptors |
| DE102007026341A1 (en) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
| GB0713686D0 (en) * | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
-
2014
- 2014-04-16 AR ARP140101624A patent/AR095883A1/en active IP Right Grant
- 2014-04-17 TW TW103114022A patent/TWI625329B/en not_active IP Right Cessation
- 2014-04-18 EA EA201591988A patent/EA028968B1/en not_active IP Right Cessation
- 2014-04-18 PT PT147861157T patent/PT2987793T/en unknown
- 2014-04-18 CA CA2909783A patent/CA2909783C/en active Active
- 2014-04-18 WO PCT/JP2014/061007 patent/WO2014171528A1/en active Application Filing
- 2014-04-18 RS RS20171324A patent/RS56865B1/en unknown
- 2014-04-18 JP JP2015512531A patent/JP6252582B2/en active Active
- 2014-04-18 US US14/256,135 patent/US8937087B2/en active Active
- 2014-04-18 NO NO14786115A patent/NO2987793T3/no unknown
- 2014-04-18 MX MX2015014646A patent/MX2015014646A/en active IP Right Grant
- 2014-04-18 HR HRP20171786TT patent/HRP20171786T1/en unknown
- 2014-04-18 LT LTEP14786115.7T patent/LT2987793T/en unknown
- 2014-04-18 ES ES14786115.7T patent/ES2651866T3/en active Active
- 2014-04-18 KR KR1020157027691A patent/KR102193247B1/en active Active
- 2014-04-18 BR BR112015026512-0A patent/BR112015026512B1/en not_active IP Right Cessation
- 2014-04-18 MY MYPI2015703694A patent/MY175971A/en unknown
- 2014-04-18 CN CN201480020846.XA patent/CN105121435B/en active Active
- 2014-04-18 NZ NZ713118A patent/NZ713118A/en not_active IP Right Cessation
- 2014-04-18 SI SI201430479T patent/SI2987793T1/en unknown
- 2014-04-18 DK DK14786115.7T patent/DK2987793T3/en active
- 2014-04-18 HU HUE14786115A patent/HUE036054T2/en unknown
- 2014-04-18 AU AU2014254768A patent/AU2014254768B2/en not_active Ceased
- 2014-04-18 SG SG11201508448RA patent/SG11201508448RA/en unknown
- 2014-04-18 SM SM20170594T patent/SMT201700594T1/en unknown
- 2014-04-18 UA UAA201511337A patent/UA116243C2/en unknown
- 2014-04-18 PL PL14786115T patent/PL2987793T3/en unknown
- 2014-04-18 EP EP14786115.7A patent/EP2987793B1/en active Active
- 2014-04-18 ME MEP-2017-277A patent/ME02891B/en unknown
- 2014-10-28 US US14/525,982 patent/US9708307B2/en active Active
-
2015
- 2015-10-07 IL IL241962A patent/IL241962B/en active IP Right Grant
- 2015-10-08 PH PH12015502341A patent/PH12015502341B1/en unknown
- 2015-10-18 SA SA515370015A patent/SA515370015B1/en unknown
-
2017
- 2017-12-06 CY CY20171101288T patent/CY1119754T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201602220B (en) | Heterocyclic compounds and uses thereof | |
| IL243420A0 (en) | Heterocyclic compounds and uses thereof | |
| ZA201506434B (en) | Heterocyclic compounds and uses thereof | |
| EP2960234A4 (en) | Trk-INHIBITING COMPOUND | |
| IL240788B (en) | Heterocyclic compounds and their uses | |
| GB201302368D0 (en) | Compound | |
| IL245301A0 (en) | Novel heterocyclic compounds | |
| IL245379A0 (en) | N-acylimino heterocyclic compounds | |
| IL241962B (en) | Heterocyclic acetamide compound | |
| IL244347A0 (en) | N-acylimino heterocyclic compounds | |
| LT3063139T (en) | Heterocyclic compound | |
| GB201307331D0 (en) | Compound | |
| GB201314960D0 (en) | Heterocyclic derivatives | |
| GB201300306D0 (en) | Heterocyclic derivatives | |
| GB201305634D0 (en) | Compound | |
| GB201304250D0 (en) | Compound | |
| GB201301585D0 (en) | Compound |